Below you find the latest publications on PubMed that discuss the FinnDiane cohort. For a complete overview click here
- INTRODUCTION: Life expectancy for people with type 1 diabetes has increased due to improved treatment of diabetes and its comorbidities, allowing many to reach old age. Still, we lack knowledge of how individuals with type 1 diabetes age. On one hand, those who reach older age can be considered survivors, but on the other hand […]
- CONCLUSIONS: Findings suggest that fracture risk assessment may need to be considered earlier than currently recommended, especially among individuals with DKD.
- CONCLUSIONS: Multimorbidity in type 1 diabetes is common and is associated with increased mortality. Comprehensive evaluation of all additional conditions is needed to tailor treatment individually.
- CONCLUSIONS: Chronic low-grade inflammation is associated with the MS in type 1 diabetes, irrespective of kidney disease severity. Hs-CRP adds to the coronary artery disease risk associated with the MS only in those without diabetic kidney disease.
- Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes was investigated. Data on 4,349 individuals without prior CAD from the Finnish Diabetic Nephropathy Study were analyzed. Central obesity was defined as waist-to-height ratio (WHtR) ≥0.5. Outcomes included acute myocardial […]
